mYXpression targets your biotherapy
Targeted biotherapy greatly increases the chances of achieving lasting remission (DAS28 <2.6). Thanks to the mYXpression rheumatoid Test, identify precisely which one suits you.
the aim is sustainable remission
Biotherapies have revolutionised the therapeutic care of rheumatoid arthritis. These new-generation treatments are very effective and have led to 2 conclusions:
A targeted biotherapysignificantly increases the chances of achieving lasting remission (DAS28 <2.6).
To date, rheumatologists only have a few elements to help them choose what to prescribe.
The mYXpression rheumatoid Testidentifies the biotherapy that is most suited to you, thereby optimising your therapeutic journey.